Table 6 Overview of base case model characteristics

Patient population

Based on FIDELIO-DKD (T2D and CKD 2–4 with moderately and severely elevated albuminuria) [13, 35]

Interventions

Finerenone on top of standard of care vs. standard of care

Time horizon

Lifetime

Cycle length

4 months

Discounting

Costs: 4.0%, QALYs: 1.5% [35]

Perspective

Societal (including costs within the healthcare system and indirect costs for patients and caregivers) [35]

Healthcare

Outcomes

ICER

WTP-threshold

€20,000